Reprinted with permission from the Foundation Fighting Blindness Blog Ophthotech, a biopharmaceutical company developing therapies for eye diseases, has enrolled the first patient in its Phase 2b clinical trial of Zimura® for people with Stargardt disease caused by mutations in the gene ABCA4.
Two Blind Brothers Support Research to End Blindness
Bradford and Bryan Manning were diagnosed with Stargardt’s disease in childhood. The disorder caused gradual loss of their central vision, and it also gave them a mission: To raise awareness and help others with eye diseases. They decided to develop
1Touch Self-Defense class increases confidence and safety
If you have low vision, you may feel vulnerable in public places. Scott Land, a gymnast and rock climber who has retinitis pigmentosa, does. Legally blind since 2000, Scott studied 1TouchTM Self Defense to learn what to do if someone
Some Addiction Treatment Programs Recognize Needs of People with Low Vision
For those with low-vision who struggle with substance abuse, the process of finding an addiction treatment program may feel daunting. While seeking to overcome an addiction, they must also face the challenge of finding a program that recognizes and respects
New Discovery: Trigger for Macular Degeneration
Researchers at University of Virginia School of Medicine have discovered an important trigger for the inflammation causing macular degeneration. Dr. Jayakrishna Ambati, vice chairman for research in UVA’s Department of Ophthalmology and the founding director of UVA’s Center for Advanced